• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,360.01 13.84
( 0.02%)
Global Indices
Nasdaq
50,746.98 -581.81
(-1.13%)
Dow Jones
7,576.82 -53.96
(-0.71%)
Hang Seng
67,369.16 -1,032.97
(-1.51%)
Nikkei 225
10,347.89 15.59
(0.15%)
Forex
USD-INR
95.24 0.16
(0.17%)
EUR-INR
110.83 0.16
(0.15%)
GBP-INR
128.25 0.32
(0.25%)
JPY-INR
0.60 0.00
(0.02%)

EQUITY - MARKET SCREENER

Fredun Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
539730
INE194R01017
514.6538079
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
38.59
1281.42
EPS(TTM)
Face Value()
Div & Yield %
60.24
10
0
 

tvs motor company ltd
SRF consolidated net profit rises 10.64% in the March 2026 quarter
May 05,2026
Net profit of SRF rose 10.64% to Rs 582.02 crore in the quarter ended March 2026 as against Rs 526.06 crore during the previous quarter ended March 2025. Sales rose 7.51% to Rs 4531.83 crore in the quarter ended March 2026 as against Rs 4215.17 crore during the previous quarter ended March 2025.

For the full year,net profit rose 46.72% to Rs 1835.18 crore in the year ended March 2026 as against Rs 1250.78 crore during the previous year ended March 2025. Sales rose 7.37% to Rs 15416.37 crore in the year ended March 2026 as against Rs 14358.15 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales4531.834215.17 8 15416.3714358.15 7
OPM %22.6322.71 -22.1218.93 -
PBDT988.62902.51 10 3238.662475.20 31
PBT768.81707.36 9 2386.591703.70 40
NP582.02526.06 11 1835.181250.78 47